Alfonso Serrano Garballo-rekin lankidetzan egindako argitalpenak (18)

2002

  1. Expansion of cells with trisomy 12 associated with progressive lymphocytosis and a dramatic change in chimera status in a patient with chronic lymphocytic leukemia.

    Haematologica, Vol. 87, Núm. 7

2001

  1. A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 230

  2. Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

    Tissue Antigens, Vol. 57, Núm. 6, pp. 508-519

  3. Expression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment

    International Journal of Cancer, Vol. 94, Núm. 2, pp. 243-251

  4. Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

    Cancer Immunology, Immunotherapy, Vol. 49, Núm. 11, pp. 621-628

  5. Re-expression of HLA class I antigens and restoration of antigen-specific cytotoxic T lymphocytes in melanoma cells following 5-AZA-2′deoxycytidine treatment

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 326

2000

  1. A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

    Immunogenetics, Vol. 51, Núm. 12, pp. 1047-1052

  2. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

    Cancer Immunology Immunotherapy, Vol. 48, Núm. 12, pp. 684-690

1999

  1. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

    International Journal of Cancer, Vol. 83, Núm. 1, pp. 91-97

  2. Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression

    Experimental Hematology, Vol. 27, Núm. 2, pp. 353-364

1998

  1. Differential expression of MHC class II genes in lung tumour cell lines

    European Journal of Immunogenetics, Vol. 25, Núm. 6, pp. 385-391

  2. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line

    Cancer Immunology Immunotherapy, Vol. 47, Núm. 2, pp. 113-120

1996

  1. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α- and γ-interferon

    Tissue Antigens, Vol. 47, Núm. 5, pp. 391-398

  2. El antigeno tumoral mage-1: estudio de su expresión y regulación genética

    El antigeno tumoral mage-1: estudio de su expresión y regulación genética

  3. Genes y moléculas de histocompatibilidad en tejidos normales y tumorales

    La genética molecular en el diagnóstico de las patologías humanas : estrategias y tecnologías : Curso de verano, A Coruña, 10 al 14 de Julio de 1995 (Servizo de Publicacións), pp. 75-88

  4. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

    Tissue Antigens, Vol. 47, Núm. 5, pp. 372-381

  5. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression

    International Journal of Cancer, Vol. 68, Núm. 4, pp. 464-470

1995

  1. Differential MAGE-1 Gene Expression in Two Variants of an Erythroleukemic Cell Line (K562)

    Immunobiology, Vol. 194, Núm. 4-5, pp. 449-456